poisar

Stocks · News reference

8-K filing — ONCOLYTICS BIOTECH INC (ONCY)

Jul 24, 2026, 8:40 PMSEC EDGAR

Filed: 2026-07-24 AccNo: 0001129928-26-000047 Size: 145 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ONCY
Source
edgar
Observed
Jul 24, 2026, 8:40 PM
Checked
Jul 24, 2026, 8:40 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  3. Aug 18, 2026, 1:03 PMBenzinga Newsdesk

    Oncolytics Biotech Receives FDA Feedback On Design Of Potential Pivotal Part B Expansion Of REO 033, Its Ongoing Randomized Study Evaluating Pelareorep In Metastatic Colorectal Cancer; Company Believes Responses Represent Important Alignment Regarding Proposed Pivotal Study Design

    Company received written feedback from the U.S. Food and Drug Administration ("FDA") regarding the design of a potential pivotal Part B expansion of REO 033, the Company’s ongoing randomized study evaluating

    Read original at benzinga
    ONCY